As of 2024-12-14, the Intrinsic Value of Edwards Lifesciences Corp (EW) is
72.49 USD. This EW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 73.32 USD, the upside of Edwards Lifesciences Corp is
-1.10%.
The range of the Intrinsic Value is 50.99 - 139.03 USD
72.49 USD
Intrinsic Value
EW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
50.99 - 139.03 |
72.49 |
-1.1% |
| DCF (Growth 10y) |
62.40 - 163.38 |
87.24 |
19.0% |
| DCF (EBITDA 5y) |
50.45 - 69.31 |
53.63 |
-26.9% |
| DCF (EBITDA 10y) |
60.75 - 86.07 |
66.62 |
-9.1% |
| Fair Value |
140.40 - 140.40 |
140.40 |
91.49% |
| P/E |
71.08 - 314.07 |
176.78 |
141.1% |
| EV/EBITDA |
41.52 - 71.29 |
54.51 |
-25.7% |
| EPV |
30.49 - 39.34 |
34.92 |
-52.4% |
| DDM - Stable |
77.08 - 304.27 |
190.67 |
160.1% |
| DDM - Multi |
40.78 - 125.37 |
61.57 |
-16.0% |
EW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
43,244.14 |
| Beta |
1.27 |
| Outstanding shares (mil) |
589.80 |
| Enterprise Value (mil) |
40,165.23 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.74% |
| Cost of Debt |
4.25% |
| WACC |
7.69% |